Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lorazepam for Sedation in Ventilated ICU Patients
NCT00095251Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Aug 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in delirium (2 arms), sponsored by Vanderbilt University. Primary endpoint: Achieving target sedation level at 120 hours. Started Aug 2004; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT00095251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095251.